Abstract: Objective In this study, the pharmacological kinetics of Buthus martensi Karsch (BmK) AS, a specific modulator of voltage-gated sodium channel site 4, was investigated on Na v 1.3 expressed in Xenopus oocytes. Methods Twoelectrode voltage clamp was used to record the whole-cell sodium current. Results The peak currents of Na v 1.3 were depressed by BmK AS over a wide range of concentrations (10, 100, and 500 nmol/L). Most remarkably, BmK AS at 100 nmol/L hyperpolarized the voltage-dependence and increased the voltage-sensitivity of steady-state activation/inactivation.
Introduction
Aberrant expression of voltage-gated sodium channels (VGSCs) underlies the hyperexcitability of neurons and severe neuropathological syndromes. VGSCs are transmembrane proteins responsible for the initiation and conduction of action potentials along axons. The electrical activity of neurons, however, has diverse functions, such as generating repetitive firing by weak stimuli [1] , amplifying subthreshold membrane potential oscillations [2] [3] [4] , and conducting action potentials with high fidelity in all excitable cells [5] . To date, it has been demonstrated that the diversity of electrophysiological activities is contingent upon different VGSC subtypes (Na v 1.1-1.9) widely distributed in various tissues [6, 7] . Although it is well-known that each VGSC subtype contributes unequally to distinct neuronal activities, the molecular mechanisms underlying this functional diversity have yet to be fully worked out.
Na v 1.3, a rapidly-repriming VGSC subtype only abundantly expressed in the embryonic and neonatal rodent central nervous system (CNS) and almost undetectable in the adult rodent CNS, has been implicated in inflammatory pain and epilepsy. However, the pathogenicity of Na v 1.3 seems to be rather obscure [8] [9] [10] [11] . increases in sensory neurons after transection [12] [13] [14] . Following spinal cord contusion injury, thalamic neurons undergo electrophysiological changes which are linked to the aberrant expression of Na v 1.3 [15] [16] [17] . In dorsal root ganglion (DRG) A-fiber neurons, the mRNA of Na v 1.3 is up-regulated after spinal nerve ligation [18] . More notably, recent studies have revealed that Na v 1.3 and its auxiliary subunit β1 are both up-regulated in the hippocampus of spontaneously epileptic rats, in which a point mutation (K354Q) within the Na v 1.3 gene motif may contribute to the abnormal neuronal firing in hippocampal neurons [19] [20] [21] .
Therefore, genetic abnormalities and aberrant electrophysiological properties of Na v 1.3 are likely to contribute to neuronal hyperexcitability in both the peripheral and central nervous systems. Despite these findings, the pathogenicity of Na v 1.3 remains unclear with regard to different expression environments in vivo due particularly to the scarcity of subtype-specific probes.
Long-chain neurotoxic polypeptides from Buthus martensi Karsch (BmK), a scorpion distributed in North China, have been reported to be specific modulators of VGSCs, either by slowing the inactivation process or by lowering the threshold for activation [22] [23] [24] [25] . Among them, BmK AS, acting on receptor site 4 on VGSCs, were found to relief inflammatory pain responses and epileptic behavior in animal models [26] [27] [28] [29] . By using electrophysiological recordings, such anti-nociceptive and anticonvulsant activities of BmK AS have been attributed to inhibition of the Na + currents through VGSCs expressed in sensory neurons [25, 29, 30] .
Interestingly, BmK AS can even induce an opposite modulation of the peak currents of VGSCs by elevating [Na + ] i in the B104 cell line [31] . More puzzling instances have also been reported in the VGSCs endogenously expressed in the DRG neuroblastoma ND7-23 cell line and in the heterologously expressed Na v 1.2 in Xenopus oocytes, both of which exhibit a U-shaped modulation of gating kinetics by BmK AS over a wide range of concentrations [25] .
To clarify the pharmacological role of BmK AS in hyperexcitability and the possible mechanisms underlying Na v 1.3-based pathology, we conducted a systematic investigation of the effects of BmK AS on Na v 1.3 expressed in Xenopus oocytes.
Materials and methods

Materials pNa3T plasmids in combination with
cDNAs encoding the rat sodium channel α-subunit rNa v 1.3α
were kind gifts from Dr. Alan L. Goldin (University of California, Irvine, USA). BmK AS was purified by column chromatography [32] from crude venom of the Asian scorpion B. martensi Karsch as described previously [33] . 
VGSC expression and electrophysiological studies
cRNA transcripts of rNa v 1.3 were synthesized from Not I (TAKARA, Japan) linearized DNA templates individually using a T7 RNA-polymerase mMESSAGE mMA-CHINETM transcription kit (Ambion, Austin, TX, USA).
Xenopus laevis oocytes were prepared [34, 35] , injected with 0.5-10 ng cRNA of rNa v 1.3, and incubated at 18-20°C for 2-4 days [36] Mean conductance (G) was calculated from peak current/voltage relations using the equation
where I is the peak current elicited upon depolarization, V is the membrane potential, and V r is the reversal potential.
The voltage-dependence of the activation was fit with the Previous work showed that 500 nmol/L BmK AS is sufficient to induce a hyperpolarizing shift in voltagedependent activation [25] . Therefore, 500 nmol/L BmK AS was chosen as the starting dose for all the following protocols to assess the responses of rNa v 1.3. Na + currents were evoked by a train of depolarizations ranging from -100 mV to +70 mV at 10 mV increments, each lasting 100 ms ( Unlike the less potent inhibition of I peak , 10 nmol/L BmK AS induced the greatest shift in voltage-dependent activation (V 1/2 ) toward a more negative potential by 9.18 ± 0.97 mV (P <0.001, n = 12), while V 1/2 was shifted by 5.34 ± 0.71 mV at 100 nmol/L (n = 14) and even less (4.08 ± 0.08 mV, n = 19) at 500 nmol/L (Fig. 3 , Table 1 ). Notably, the hyperpolarizing shift of activation by 500 nmol/L BmK AS could be relieved after a 10 min period of washing (data not shown). In addition, the slope factor (k) of the activation curve, indicating the range of voltage sensitivity, was slightly increased by BmK AS (1.55 mV for 10 nmol/L, 1.27 mV for 100 nmol/L and 2.04 mV for 500 nmol/L) ( (Table 1) . Contrary to the comparatively weak binding affinity with rNa v 1.3 in the activation process at high concentration, BmK AS at all concentrations was hardly dis- .96 mV for 100 nmol/L and 3.14 mV (P <0.001) for 500 nmol/L), similar to that in the activation process (Table 1) .
Therefore, the steady-state inactivation of rNa v 1.3 was also modulated by BmK AS in a nonlinear manner. The voltage-dependence of fast and slow inactivation was studied using prepulses of different durations (10 ms For voltage-dependent activation/inactivation, the values of half-maximum activation/inactivation voltage V 1/2 and corresponding slope factor (k) were determined in the absence and presence of BmK AS. For recovery, total recovery of sodium channels is indicated as A and τ rec is the time constant of recovery. The data are mean ± SEM and n is the number of independent experiments. *** 215 for fast and 2 s for slow inactivation) (insets in Fig. 5 ).
Both 10 and 500 nmol/L BmK AS had a significant effect on fast inactivation, shifting the half-maximum inactivation potential more negative (V 1/2 ) by 8.26 ± 0.09 mV (P <0.001, n = 9) and 9.82 ± 0.31 mV (P <0.001, n = 10)
respectively. Unexpectedly, 100 nmol/L BmK AS hardly shifted the voltage-dependent fast inactivation. The change of slope factor of fast inactivation was less than that of the steady-state inactivation and activation processes, increased by 0.69 mV for 10 nmol/L (P <0.001, n = 9), 1.26 mV for 100 nmol/L (P <0.001, n = 12) and 1.45 mV for 500 nmol/L (P <0.001, n = 10) (Fig. 5 , Table 1 ). However, k was remarkably decreased by 2.46 mV after washing, compared to the control, indicating an expansion in voltage-sensitivity during the administration (Table 1 ).
In the case of slow inactivation, BmK AS shifted the ± 0.47 mV (P <0.001, n = 9) and 13.46 ± 0.36 mV (P < 0.001, n = 10), respectively (Fig. 5, Table 1 ). Despite the pronounced change in slow inactivation kinetics, the hyperpolarized V 1/2 almost returned to the control level after washing, except for k that still had a significant negative (Table 1) .
Thus, BmK AS modulated both fast and slow inactivation of rNa v 1.3 in a nonlinear manner, with more effect on slow inactivation.
Nonlinear dose-effect acceleration of recovery from
BmK AS To correlate the inactivation and recovery from inactivation of rNa v 1.3 in the presence of BmK AS, the recovery kinetics of currents were measured at a recovery voltage of -120 mV and single exponential fits were used to estimate the recovery time constants.
The rate of recovery was accelerated to variable extents by different doses of BmK AS. The acceleration of recovery kinetics from 100 nmol/L BmK AS was the most notable (Δτ rec = 2.17 ± 0.10 ms, n = 9), while 10 and 500 nmol/L were less efficient (Δτ rec = 1.81 ± 0.09 ms, n = 7
and Δτ rec = 2.02 ± 0.09 ms, n = 7) (Fig. 6 , Table 1 ). At all concentrations, BmK AS shifted the voltage-dependence of recovery in the hyperpolarized direction (Fig. 6 ), leading to is the only VGSC subtype that has up-regulated expression in injured neurons [12] [13] [14] 17, 18] . Na v 1.3 currents exhibit slow development of closed-state inactivation and rapid repriming kinetics in response to depolarizing stimuli [37] . The distinct functional properties of Na v 1.3 may be important for developing neurons and also contribute to aberrant activity in injured neurons.
In the present study, we expressed the rNa v 1.3 α subunit alone in Xenopus oocytes to specifically investigate the pharmacology of BmK AS, a VGSC site 4-specific modulator, on Na v 1.3. The fact that the electrophysiological profiles of one type of channel may vary in different expression systems does not affect our goal to assess the pharmacological modulation of Na v 1.3 by BmK AS. Indeed, our data demonstrated a more negative shift in activation by -10 mV than a previous report which also used Xenopus oocytes [21] , and this is close to the value expressed in HEK 293 cells [37] . However, the shift in inactivation kinetics appeared to be more profoundly depolarized than that of Na v 1.3 expressed in HEK 23 cells or axotomized DRG neurons [37] . The subtle variances may be attributed the comparatively longer time of channel expression required to ensure robust currents, which did not influence the following studies. Another possibility may lie in the lack of β subunits, which has been demonstrated to result in a similar functional contrast [21, 38] .
The nonlinear dose-effect curve for BmK AS was first assessed on Na v 1.2 expressed in Xenopus oocytes and ND7-23 cells. For Na v 1.2, BmK AS was found to depolarize the voltage-dependent activation and inactivation at low (0.1 nmol/L) and high concentrations, but hyperpolarize the activation and inactivation kinetics at a medium concentration (1 nmol/L) [25] . Interestingly, in ND7-23 cells that express a mixture of TTX-sensitive VGSCs, mainly Na v 1.6 and Na v 1.7 [39] , over a wide range of concentrations (i.e., 10, 100 and 500 nmol/L). This dual potency seems to be a common feature among other known β-like toxins that are toxic to both mammal and insects, such as BmK AS-1, AaH IT4 and Lqhβ1 [40] .
Like AaH IT4, BmK AS/AS-1 competes with antiinsect scorpion toxins for binding to the sodium channel of insects at a site with high affinity but low capacity; it also competes with the binding of α-type scorpion toxins to the mammalian sodium channel at a low affinity but high capacity binding site [41, 43] . Generally, α-type scorpion toxins, defined as VGSC site 3-specific modulators, target VGSCs by inhibiting the inactivation and recovery, while β-type anti-insect scorpion toxins, defined as VGSC site 4-specific modulators, facilitate the activation and depress the peak currents of VGSCs [44, 45] . Hence, it is reasonable to assume that BmK AS can bind to both sites 3 and 4, modulating both voltage-dependent activation and inactivation of VGSCs.
BmK AS tended to bind with site 3 to modulate inactivation more at the medium concentration, while binding with site 4 at low or high concentrations caused more of a negative-shift of the activation. In terms of these multifaceted features, BmK AS resembles another β-like toxin, Lqhβ1, which induces a shift in the voltage-dependent activation to more negative membrane potentials and a reduction in peak sodium currents, as well as having a weak effect on inactivation of cardiac VGSCs and a marked effect on rat brain and skeletal muscle VGSCs [40] .
It is noteworthy that BmK AS had a comparably stronger modulation of inactivation than activation, which was inferred by the finding that the shift in voltage-dependent inactivation by BmK AS was far more difficult to remove by washing compared to the almost full recovery of BmK AS-modified voltage-dependent activation. Therefore, the tight binding of BmK AS with the inactivation gate of the channel may result in a shift in recovery kinetics and an overall reduction in peak currents even after washing.
Considering the fact that site 4-specific modulators facilitate activation by binding to the DII S3/S4 loop in VGSCs [46] while site 3-specific modulators delay inactivation by binding to DIV S4 [43] , we may infer that BmK AS binds with the DII S3/S4 loop and DIV S4 in particular. More supportive evidence came from the finding that the slow inactivation kinetics were more readily modulated than the fast inactivation by BmK AS, in that the molecular determinants of slow inactivation are considered to be more closely associated with the charged residues within DIV S4 [47] . However, this inference should be interpreted with caution until more evidence from molecular site-directed mutagenesis is available.
Pathogenetic insights into Na v 1.3 probed by BmK
AS It has been shown that spinal contusion leads to a shift of the steady-state activation and inactivation of the sodium current towards more depolarized potentials. The shifted steady-state inactivation shows similarities to that in axotomized DRGs, which is attributed to upregulated Na v 1.3 expression [16, 17] . These observations imply a sub- A marked finding of this study was that BmK AS inhibited the peak current of Na v 1.3 at all concentrations tested. The inhibition of Na + currents is in accord with the previous experiments on pathology, i.e., the nociceptive responses induced by formalin or carrageenan are markedly reduced after BmK AS administration [26] [27] [28] . Accordingly, the seizure-like behavior and cortical epileptiform EEG in epileptic rats are remarkably suppressed by BmK AS [29] . However, this anti-convulsant activity of BmK AS seems to differ among epileptic models, being efficient in pentylenetetrazole-evoked seizures but ineffective in pilocarpine-induced epileptiform behavior [29] . The relative strength of the opposing effects may depend on the toxin concentration and the VGSC subtypes affected [25] .
Although the inhibition of Na + current by BmK AS is apparent in heterologously expressed VGSCs, the intracellular Na + concentration is unexpectedly elevated by 500 nmol/L BmK AS in the B104 neuroblastoma cell line [48] , in which Na v 1.3 and Na v 1.6 are dominantly expressed [49] . The 
